Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADME of [14C]-Vixotrigine in Healthy Male Subjects
NCT02751905Phase 1Completed
- Sponsor
- Biogen
- Start
- Apr 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vixotrigine in neuropathic pain, sponsored by Biogen. Primary endpoints: Urinary amount excreted per sampling interval (Aeu), Fecal amount excreted per sampling interval (Aef) and 11 more. Started Apr 2016; status: completed.
02
Drugs
vixotrigine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02751905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02751905.